Menu

Telehealth Coverage Policies in the Time of COVID-19 to Date

An image for Telehealth Coverage Policies in the Time of COVID-19 to Date

Timestamp: April 30, 2020 – 3 pm PT

As things rapidly develop on both what we know about COVID-19, policies around telehealth have also been developing alongside of it. PHI’s Center for Connected Health Policy has created a summary of what is covered by various public and private payers with the information that has been released.

Download "Telehealth Coverage Policies in the Time of COVID-19 to Date"

Please note that events are evolving; consider this a living document that could change frequently as new information and new policies become available/are enacted. CCHP will continue to make updates when they become available.

As of 4/30/2020, CCHP has also released an additional fact sheet on FQHCs and Rural Health Clinics: Federally Qualified Health Centers & Rural Health Clinics Acting as Distant Site Providers in Medicare


PHI’s Center for Connected Health Policy (CCHP) is the federally designated national telehealth policy resource center. CCHP provides technical assistance, education and creates resources and materials related to telehealth policy and consults frequently with federal and state policymakers, health plans, providers, national organizations and others.


Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org